Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Catalent Inc | CTLT | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
55.95 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 31.45 - 60.20 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 55.95 | USD |
Catalent (CTLT) Options Flow Summary
Catalent Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
10.11B | 180.74M | - | 4.26B | -256M | -1.42 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Catalent News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CTLT Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 55.75 | 56.53 | 55.42 | 55.88 | 1,612,950 | 0.20 | 0.36% |
1 Month | 56.48 | 57.1999 | 55.42 | 56.35 | 1,623,321 | -0.53 | -0.94% |
3 Months | 51.78 | 60.20 | 51.60 | 57.26 | 2,816,293 | 4.17 | 8.05% |
6 Months | 41.86 | 60.20 | 31.8001 | 49.44 | 2,507,663 | 14.09 | 33.66% |
1 Year | 44.63 | 60.20 | 31.45 | 45.30 | 2,943,838 | 11.32 | 25.36% |
3 Years | 115.00 | 142.64 | 31.45 | 63.92 | 2,056,196 | -59.05 | -51.35% |
5 Years | 44.13 | 142.64 | 31.04 | 66.94 | 1,669,101 | 11.82 | 26.78% |
Catalent Description
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents. |